Support PenkeIncyte Corporation - Trending symbols
Latest News of Incyte Corporation
| Date | Title | Read |
|---|---|---|
| 2025-08-01 15:34 | Avis Budget downgraded, Sprouts upgraded: Wall Street's top analyst calls | Read |
| 2025-07-29 18:35 | Uncover the latest developments among S&P500 stocks in today's session. | Read |
| 2025-07-29 17:45 | INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales | Read |
| 2025-07-16 22:04 | Incyte EVP Flannelly sells $83k in shares | Read |
| 2025-07-09 16:09 | William Blair Maintains ‘Hold’ Rating on Incyte Corporation (INCY), Citing Future Revenue Uncertainties | Read |
| 2025-07-06 15:05 | Notable healthcare headlines for the week: Novo Nordisk, Eli Lilly, AbbVie and Centene in focus | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-07-30 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation and Amortization | 22,048 | 472 | 22,520 | 213 | 22,733 | -371 | 22,362 | -44,724 | -22,362 | |
| Income before Tax | 277,604 | -43,805 | 233,799 | 37,157 | 270,956 | -34,797 | 236,159 | -625,936 | -389,777 | |
| Net Income | 203,548 | -32,279 | 171,269 | 29,810 | 201,079 | -31,531 | 169,548 | -614,149 | -444,601 | |
| EBIT | 244,822 | -5,562 | 239,260 | 13,504 | 252,764 | -116,578 | 136,186 | -613,423 | -477,237 | |
| EBITDA | 265,119 | -4,469 | 260,650 | 13,876 | 274,526 | -116,393 | 158,133 | -613,322 | -455,189 | |
| Operating Income | 193,780 | 20,925 | 214,705 | -27,435 | 187,270 | -95,372 | 91,898 | -569,135 | -477,237 | |
| Net Income from Continuing Operations | 203,548 | -32,279 | 171,269 | 29,810 | 201,079 | -31,531 | 169,548 | -614,149 | -444,601 | |
| Accumulated Other Comprehensive Income | 20,942 | 5,864 | 26,806 | -3,912 | 22,894 | -9,788 | 13,106 | -19,278 | -6,172 | |
| Retained Earnings | -437,214 | 21,703 | -415,511 | 203,548 | -211,963 | 171,269 | -40,694 | 201,079 | 160,385 | |
| Cost of Revenue | 50,636 | 3,964 | 54,600 | 4,563 | 59,163 | -2,341 | 56,822 | -59,022 | -2,200 | |
| Net Interest Income | -680 | 2 | -678 | 37 | -641 | -26 | -667 | 33,071 | 32,404 | |
| Other Stockholders Equity | 4,420,902 | 56,476 | 4,477,378 | 31,429 | 4,508,807 | 58,304 | 4,567,111 | -4,590,158 | -23,047 | |
| Interest Expense | 428 | -69 | 359 | -1 | 358 | 81 | 439 | -3,503 | -3,064 | |
| Tax Provision | 18,252 | -2,465 | 15,787 | 6,390 | 22,177 | 5,553 | 27,730 | -471,561 | -443,831 | |
| Income Tax Expense | 18,252 | -2,465 | 15,787 | 6,390 | 22,177 | 5,553 | 27,730 | -471,561 | -443,831 |
Comments
How you think about this?